The primary evidence that there is not a contribution from central AT1 receptors overactivity to the hypertension in BPH/2J mice is based on the equal or smaller depressor response to acute central AT1 receptor inhibition in BPH/2J compared with BPN/3J mice. The gene discussed is AGTR1; the disease is benign prostatic hyperplasia.